Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds


Breast carcinoma is the most common malignancy among women in developed countries. Because family history remains the strongest single predictor of breast cancer risk, attention has focused on the role of highly penetrant, dominantly inherited genes in cancer-prone kindreds1. BRCA1 was localized to chromosome 17 through analysis of a set of high-risk kindreds2, and then identified four years later by a positional cloning strategy3. BRCA2 was mapped to chromosomal 13q at about the same time4. Just fifteen months later, Wooster et al.5 reported a partial BRCA2 sequence and six mutations predicted to cause truncation of the BRCA2 protein. While these findings provide strong evidence that the identified gene corresponds to BRCA2, only two thirds of the coding sequence and 8 out of 27 exons were isolated and screened; consequently, several questions remained unanswered regarding the nature of BRCA2 and the frequency of mutations in 13q-linked families. We have now determined the complete coding sequence and exonic structure of BRCA2 (GenBank accession ♯U43746), and examined its pattern of expression. Here, we provide sequences for a set of PCR primers sufficient to screen the entire coding sequence of BRCA2 using genomic DMA. We also report a mutational analysis of BRCA2 in families selected on the basis of linkage analysis and/or the presence of one or more cases of male breast cancer. Together with the specific mutations described previously, our data provide preliminary insight into the BRCA2 mutation profile.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others


  1. Kelsey, J.L. & Gammon, M.D. The epidemiology of breast cancer. CA Cancer J. Clinic. 41, 147–165 (1991).

    Article  Google Scholar 

  2. Hall, J.M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 250, 1684–1689 (1990).

    Article  CAS  PubMed  Google Scholar 

  3. Miki, Y. et al. A strong candidated for the 17q-linked breast and ovarian cancer susceptibility gene BRCA1. Science. 266, 66–71 (1994).

    Article  CAS  PubMed  Google Scholar 

  4. Wooster, R. et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 265, 2088–2090 (1994).

    Article  CAS  PubMed  Google Scholar 

  5. Wooster, R. et al. Identification of the breast cancer gene BRCA2. Nature. 378, 789–791 (1995).

    Article  CAS  PubMed  Google Scholar 

  6. Schutte, M. et al. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc. Natl. Acad. Sci. USA. 92, 5950–5954 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Stone, S. et al.Complex structure and regulation of the P16 (MTS1) locus. Cancer Res. 55, 2988–2994 (1995).

    CAS  PubMed  Google Scholar 

  8. Simard, J. et al. Generation of a transcription map of the BRCA2 region. Am. J. Hum. Genet. 57, (suppl) 1566 (1995).

    Google Scholar 

  9. Friedman, L.S. et al. Novel inherited mutations and variable expressivity of BRCA1 alleles including the founder mutation 185 del AG in Ashkenazi Jewish families. Am. J. Hum. Genet. 57, 1284–1297 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Szabo, C.I. & King, M.-C. Inherited breast and ovarian cancer. Hum. Mol.Genef. 4, 1811–1817 (1995).

    Article  CAS  Google Scholar 

  11. Shattuck-Eidens, D. et al. A comparative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implication for presymptomatic testing and screening. JAMA. 273, 535–541 (1995).

    Article  CAS  PubMed  Google Scholar 

  12. Parimoo, S. et al. cDNA selection: Efficient PCR approach for the selection of cDNAs encoded in large chromosomal DNA fragments. Proc. Natl. Acad. Sci. USA. 88, 9623–9627 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Rommens, J.M. et al. Towards a transcriptional map of the q21 -q22 region of chromosome 7. In ‘Identification of transcribed sequences’, (eds Hochgeschwender, U. & Gardiner, K.) pp. 65–79 (Plenum Press, New York, 1994).

    Chapter  Google Scholar 

  14. Lovett, M., Kere, J. Direct selection: A method for the isolation of cDNAs encoded by large genomic regions. Proc. Natl. Acad. Sci. USA. 88, 9628–9632 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Nattier, T. et al. Analysis of hybrid selection in the search for BRCA1. Mamm. Genome 6, 873–879 (1995).

    Article  Google Scholar 

  16. Church, D.M. et al. Identification of human chromosome 9 specific genes using exon amplification. Hum. Mol. Genet. 2, 1915 (1993).

    Article  CAS  PubMed  Google Scholar 

  17. Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8, 22–29 (1994).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Tavtigian, S., Simard, J., Rommens, J. et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12, 333–337 (1996).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing